Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-11
2007-12-11
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S394000, C546S082000, C548S302100
Reexamination Certificate
active
10551049
ABSTRACT:
The invention relates to cyclic benzimidazoles of formula 1,in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
REFERENCES:
patent: 2007/0037840 (2007-02-01), Buhr
patent: 0 266 326 (1988-05-01), None
patent: 95/27714 (1995-10-01), None
patent: 97/47603 (1997-12-01), None
patent: 03/014123 (2003-02-01), None
patent: WO 03014123 (2003-02-01), None
patent: 2004/054984 (2004-07-01), None
Kaminski, J.J. et al., “Antiulcer Agents. 5. Inhibition of Gastric H+/K+-ATPase by Substituted Imidazo[1,2-a]pyridines and Related Analogues and Its Implication in Modeling the High Affinity Potassium Ion Binding Site of the Gastric Proton Pump Enzyme”,J. Med. Chem., vol. 34, pp. 533-541 (1991).
Kaminski, J.J. et al., “Antiulcer Agents. 6. Analysis of the in Vitro Biochemical and in Vivo Gastric Antisecretory Activity of Substituted Imidazo[1,2-a]pyridines and Related Analogues Using Comparative Molecular Field Analysis and Hypothetical Active Site Lattice Methodologies”,J. Med. Chem., vol. 40, pp. 427-436 (1997).
Lanas, et al., “Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment”,Curr. Med. Res. Opin, 23(1); pp. 163-173 (2007).
Rey, et al., “Use of antisecretory drugs among consumers of non-steroidal anti-inflammatory drugs in the general population”, Ailment Pharmcol. Ther., vol. 24, pp. 1585-1592 (2006).
Pham, et al., “Acid Suppressive Therapy Use on an Inpatient Internal Medicine Service”,Ann. Pharmacother., vol. 40, pp. 1261-1266 (2006).
Lanza, “A Guideline for the Treatment and Prevention of NSAID-induced Ulcers”,The American Journal of Gastroenterology, vol. 93, No. 11 (1998).
Buhr Wilm
Chiesa M. Vittoria
Zimmermann Peter Jan
Altana Pharma AG
Anderson Rebecca
Barker Michael P.
Goldberg Joshua B.
McGee Sheldon M.
LandOfFree
Cyclic benzimidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic benzimidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic benzimidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898328